Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy

Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura

NCT04056507 ·Status: COMPLETED

Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia

NCT04870346 ·Status: ACTIVE_NOT_RECRUITING

PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES

NCT06159816 ·Status: COMPLETED

Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)

NCT03469661 ·Status: COMPLETED

Observatory of Immunological Thrombopenic Purpura in the Brest Region

NCT06556888 ·Status: RECRUITING

An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

NCT01633372 ·Status: COMPLETED ·Phase: PHASE2

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

NCT05931718 ·Status: RECRUITING

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

NCT01933035 ·Status: COMPLETED

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

NCT06693791 ·Status: RECRUITING ·Phase: PHASE2

A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis

NCT02087059 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

NCT00037791 ·Status: COMPLETED ·Phase: PHASE3

Hematological Response in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5 Antibody: an External Control Arm Study for Iptacopan Use in Anti-C5 naïve Patients

NCT05842486 ·Status: COMPLETED

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

NCT01013181 ·Status: COMPLETED

Observational Study of Blinatumomab

NCT03117621 ·Status: COMPLETED

Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.

NCT07212426 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

NCT04539678 ·Status: COMPLETED

Safety of Romiplostim (Nplate®) Following UCBT

NCT02046291 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

NCT03998059 ·Status: RECRUITING

Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia

NCT02055781 ·Status: TERMINATED ·Phase: PHASE3

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

NCT01101295 ·Status: UNKNOWN

Dual Vaccine Trial in Myeloproliferative Neoplasms

NCT04051307 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Research of Predictive Factors to Immune Thrombopenic Purpura

NCT01648556 ·Status: COMPLETED ·Phase: NA

Biologic Characterization of Patients With ITP

NCT05694325 ·Status: RECRUITING ·Phase: NA

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

NCT05613296 ·Status: COMPLETED

Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

NCT06009965 ·Status: UNKNOWN ·Phase: PHASE4